Article
Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma.
Current medicinal chemistry - 1 Jan 2024
Kozyra Paweł, Pitucha Monika
Abstract excerpt
Malignant melanoma is the rarest but most aggressive and deadly skin cancer. Melanoma is the result of a malignant transformation of melanocytes, which leads to their uncontrolled proliferation. Mutations in the mitogen-activated protein kinase (MAPK) pathway, which are crucial for the control of cellular processes, such as apoptosis, division, growth, differentiation, and migration, are one of its most common...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
